Conference Coverage

Investigating the Links Between MS Drugs, Autoimmune Disease, and Disease Progression

Neurology Reviews. 2013 September;21(9):22

 

References

—Erik Greb
Senior Associate Editor

Pages

Recommended Reading

Mark Freedman, MD
MDedge Neurology
Evidence-based medical marijuana for MS symptoms
MDedge Neurology
Selecting the right oral MS drug
MDedge Neurology
Analysis: Healthy babies born after accelerated elimination of teriflunomide
MDedge Neurology
Monoclonal Antibodies Could Become Popular Treatments for MS
MDedge Neurology
New and Noteworthy Information—August 2013
MDedge Neurology
Recommendations Outline How to Improve Dimethyl Fumarate Tolerability in MS
MDedge Neurology
Fingolimod heart effects usually resolve within 6 hours
MDedge Neurology
Heart Effects of Fingolimod May Resolve Within Six Hours
MDedge Neurology
New and Noteworthy Information—September 2013
MDedge Neurology